financetom
Business
financetom
/
Business
/
Ticket reseller StubHub's IPO 20 times oversubscribed, source says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ticket reseller StubHub's IPO 20 times oversubscribed, source says
Sep 12, 2025 11:37 AM

By Ateev Bhandari

Sept 12 (Reuters) - Ticket reseller StubHub, which

delayed its U.S. listing in April amid market volatility, has

drawn over 20 times as many orders for its planned initial

public offering as there are available shares, a source familiar

with the matter said on Friday.

The outsized demand for the IPO, which is set to price

shares on Tuesday, reflects pent-up investor appetite for

tech-heavy consumer platforms.

StubHub did not immediately respond to Reuters' request for

comment.

Madrone Partners-backed StubHub had postponed its IPO

roadshow earlier this year as U.S. President Donald Trump's

tariffs roiled global markets and froze all dealmaking.

In a stark turn of events, U.S. IPOs have had a triumphant

week as companies ranging from crypto to consumer tapped the

public markets amid record high equity markets and easing tariff

worries.

Swedish buy-now, pay-later firm Klarna's ( KLAR ) shares

jumped in its long-awaited debut earlier this week, reinforcing

bullish investor sentiments for fintechs.

Separately, cafe chain Black Rock Coffee Bar's

shares rose above their issue price earlier in the day, as

investors brushed off residual concerns over the consumer

company's health.

StubHub is targeting a valuation of up to $9.2 billion in

its U.S. IPO, seeking to raise up to $851 million by offering 34

million shares priced between $22 and $25 each.

The company was co-founded in 2000 by Jeff Fluhr and current

CEO Eric Baker, who had exited StubHub ahead of its $310-million

sale to e-commerce firm eBay ( EBAY ) in 2007.

Baker in 2006 launched viagogo, a rival ticket reseller in

Europe, which in 2020 bought StubHub from eBay ( EBAY ) for $4.05

billion.

J.P. Morgan and Goldman Sachs are the lead underwriters of

the offering.

StubHub will list on the New York Stock Exchange under the

ticker symbol "STUB".

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ElevateOS Acquires RightFit Personal Training, Unlocking Wellness-Driven NOI and Renewal Gains for Multifamily Owners
ElevateOS Acquires RightFit Personal Training, Unlocking Wellness-Driven NOI and Renewal Gains for Multifamily Owners
Nov 10, 2025
CHICAGO, Nov. 10, 2025 /PRNewswire/ -- ElevateOS, the white-labeled community operating platform for multifamily real estate, today announced the acquisition of RightFit Personal Training (rightfitpersonaltraining.com), one of the nation's largest marketplaces for certified personal trainers. The acquisition deepens ElevateOS's vertically integrated services marketplace and accelerates wellness programming across communities—turning underused amenity spaces into high-engagement, high-ROI experiences and ancillary revenue beyond...
Arcutis Biotherapeutics Insider Sold Shares Worth $732,927, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $732,927, According to a Recent SEC Filing
Nov 10, 2025
05:47 PM EST, 11/10/2025 (MT Newswires) -- Larry Todd Edwards, Executive Vice President, Chief Commercial Officer, on November 06, 2025, sold 29,131 shares in Arcutis Biotherapeutics ( ARQT ) for $732,927. Following the Form 4 filing with the SEC, Edwards has control over a total of 150,193 common shares of the company, with 150,193 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1787306/000199480525000008/xslF345X05/wk-form4_1762814533.xml...
Plant-based meat maker Beyond Meat Q3 revenue falls, net loss widens
Plant-based meat maker Beyond Meat Q3 revenue falls, net loss widens
Nov 10, 2025
Overview * Beyond Meat ( BYND ) Q3 revenue falls 13.3% yr/yr but beats analyst expectations * Company reports Q3 net loss of $110.7 mln, impacted by impairment charges * Adjusted EBITDA loss widens to $21.6 mln, reflecting operational challenges Outlook * Company expects Q4 2025 net revenues between $60 mln and $65 mln * Beyond Meat ( BYND )...
Arcutis Biotherapeutics Insider Sold Shares Worth $417,145, According to a Recent SEC Filing
Arcutis Biotherapeutics Insider Sold Shares Worth $417,145, According to a Recent SEC Filing
Nov 10, 2025
05:48 PM EST, 11/10/2025 (MT Newswires) -- Patrick Burnett, Executive Vice President and Chief Medical Officer, on November 06, 2025, sold 17,250 shares in Arcutis Biotherapeutics ( ARQT ) for $417,145. Following the Form 4 filing with the SEC, Burnett has control over a total of 98,325 common shares of the company, with 98,325 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1787306/000174198725000008/xslF345X05/wk-form4_1762814517.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved